Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHIRON STOCK GAINS 20.4% TO 22-7/8 IN OCTOBER ON STRONG THIRD QUARTER RESULTS; O-T-C INDEX FALLS 2.3% IN OCTOBER AS LOSERS OUTNUMBER GAINERS BY TWO TO ONE

This article was originally published in The Gray Sheet

Executive Summary

Chiron stock bounced back in October from a summer slide, advancing 3-7/8 (20.4%) to 22-7/8 during the month with the aid of strong third quarter sales and earnings. The gain was the first upward momentum in four months for Chiron, which was hit particularly hard during the summer sell-off of technology and biotech issues.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel